Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bone graft & orthobiologics · Iowa | Bone graft & orthobiologics · Michigan | |
|---|---|---|
| Surgeons, 2024 | 8 | 27 |
| Medicare fee-for-service cases | 349 | 796 |
| Growth since 2019 (Medicare FFS) | +3.2%/yr | −14%/yr |
| Forecast cases (Medicare FFS) | 470 in 2030 | 740 in 2030 |
| Forecast growth | +5.1%/yr to 2030 | −1.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.8 | 0.9 |
| Medicare Advantage share | 40% | 66% |
| Out of hospital | 0% (+0 pts since 2019) | 3% (+2 pts since 2019) |
| Cases per surgeon | 44 | 29 |
| Top 10 surgeons' share | 100% | 60% |
| Surgeons growing | 2 | 2 |
| New since the base year | 2 | 2 |
| Likely to stop billing it | 3 by 2026 | 10 by 2026 |
| Forecast miss, 1 year (procedure) | 12% | 12% |
| Company payments per surgeon | $2,571 | $5,896 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.